idr-1 test injected mice idr-1 days hours infecting vre mrsa treated mice nearly twice likely survive infection group reports week hancock co founded company commercialize idr-1 says peptide not kill bacteria directly instead prime body quick dirty immune response called innate immunity subsequent infection says flag body send surplus white blood cells called monocytes macrophages gobble invading pathogens fewer aggressive neutrophils likely induce sepsis hancock says clinical trials idr-1 begin 12 15 months adds preliminary evidence suggests peptide enhance effectiveness antibiotics mice superbugs vre jr minkel news reporter march 19 2007 nikhil swaminathan december 4 2006 nikhil swaminathan november 3